Lab-grown immune cells take on lung cancer in new trial
NCT ID NCT07202611
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 26 times
Summary
This study tests a new treatment for people with advanced non-small cell lung cancer (stage IIIB or IV) who have already tried at least two other therapies. The treatment uses the patient's own immune cells—dendritic cells and natural killer cells—grown in a lab and then given back via injection or infusion. The main goal is to check safety, but researchers will also see if the cells can shrink tumors or slow the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Taiwan University Hospital Yunlin Branch
RECRUITINGHuwei, YUNLIN, 640, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.